Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Acute Spinal Cord Injury (SCI)Acute Spinal Cord Injury of Traumatic Origin (tSCI)
Interventions
DEVICE

transcutaneous spinal cord stimulation

Transcutaneous spinal stimulation will be delivered using the experimental ARC-EX device (ONWARD Medical), via skin surface electrodes placed over the spine (stimulating electrodes) and bilaterally on the iliac crests (reference electrodes) during the intervention.

DEVICE

sham transcutaneous spinal cord stimulation

For sham transcutaneous spinal stimulation electrodes will be placed on the skin surface over the spine and bilaterally on the iliac crests and will be attached to the experimental ARCEX device (ONWARD Medical), however no electrical current will be delivered.

Trial Locations (1)

94110

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of California, San Francisco

OTHER

NCT07090473 - Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes | Biotech Hunter | Biotech Hunter